Download PDF
CC BY-NC-ND 4.0 · Homeopathy 2019; 108(02): 139-148
DOI: 10.1055/s-0038-1676810
Debate
The Faculty of Homeopathy

Isopathic Use of Auto-Sarcode of DNA as Anti-Miasmatic Homeopathic Medicine and Modulator of Gene Expression?

Marcus Zulian Teixeira
1   School of Medicine, University of São Paulo, São Paulo, Brazil
› Author Affiliations Funding None.
Further Information

Publication History

23 July 2018

25 October 2018

Publication Date:
13 February 2019 (online)

   Permissions and Reprints

Abstract

Introduction In addition to the four pillars of homeopathy, vitalism and the miasmatic theory are often used to explain the health–disease process. According to Hahnemann's concepts, homeopathic miasms are the main obstacle to the cure of chronic diseases, with psora being the fundamental cause of all forms of diseases. According to modern genetics, the disease-promoting epigenetic alterations are the fundamental cause of the manifestation of chronic diseases.

Objective This article develops a philosophical–scientific correlation between chronic miasms and disease-promoting epigenetic modifications, aiming to justify the isopathic use of auto-sarcode of an individual's DNA as homeopathic medicine.

Results Based on the study of homeopathic doctrine and epigenetics, a conceptual and functional correlation is observed between homeopathic chronic miasms and disease-promoting epigenetic modifications. Additionally, several experimental studies suggest that homeopathy's mechanism of action may be by modulating gene expression.

Conclusions By the philosophical–scientific correlations described, it is inferred that disease-promoting epigenetic alterations are the biological representation of the chronic miasms, suggesting the isopathic use of auto-sarcode of DNA as homeopathic therapeutic modulator of gene expression for the management of chronic diseases.

Keywords

homeopathy - miasm - epigenome - isopathy - auto-sarcode of DNA

Highlights

• Vitalism and miasmatic theory are used to broaden the understanding of the health–disease process.

• The chronic miasms are the main obstacle to the homeopathic healing of chronic diseases.

• Disease-promoting epigenetic modifications are the biological representation of the chronic miasms.

• Anti-miasmatic homeopathic medicines are used to cure the miasms and their consequent chronic diseases.

• Isopathic use of auto-sarcode of DNA can be employed as anti-miasmatic homeopathic medicine and gene expression modulator.


 

  • References

  • 1 Teixeira MZ. Proofs that homeopathic medicine works: dossier “scientific evidence for homeopathy” (Revista de Homeopatia, São Paulo Homeopathic Medical Association). Homeopathy 2018; 107: 45
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Teixeira MZ. Special dossier: “Scientific Evidence for Homeopathy”. Rev Assoc Med Bras (1992) 2018; 64: 93-94
    CrossrefPubMedGoogle Scholar
  • 3 Hahnemann S. Organon der Heilkunst. Organon da arte de curar. 6th ed. Ribeirão Preto: Museu de Homeopatia Abrahão Brickmann; 1995
    Google Scholar
  • 4 Teixeira MZ. A concepção vitalista de Samuel Hahnemann [The vitalist conception of Samuel Hahnemann]. Rev Homeopatia (São Paulo) 1996; 61: 39-44
    PubMedGoogle Scholar
  • 5 Teixeira MZ. Antropologia Médica Vitalista: uma ampliação ao entendimento do processo de adoecimento humano [Vitalist Medical Anthropology: a broadening to the understanding of the human illness process]. Rev Med (São Paulo) 2017; 96: 145-158
    PubMedGoogle Scholar
  • 6 Hahnemann S. The Chronic Diseases, their peculiar nature and their homeopathic cure. Translated from the second enlarged German edition of 1835 by Prof. Louis H. Tafel. With annotations by Richard Hughes. Edited by Pemberton Dudley. Available at: http://homeoint.org/books/hahchrdi/index.htm . Accessed September 20, 2018
    PubMedGoogle Scholar
  • 7 Venter JC, Adams MD, Myers EW. , et al. The sequence of the human genome. Science 2001; 291: 1304-1351
    CrossrefPubMedGoogle Scholar
  • 8 Holliday R. Epigenetics: a historical overview. Epigenetics 2006; 1: 76-80
    CrossrefPubMedGoogle Scholar
  • 9 Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705
    CrossrefPubMedGoogle Scholar
  • 10 García R, Ayala PA, Perdomo SP. Epigenética: definición, bases moleculares e implicaciones en la salud y en la evolución humana [Epigenetics: definition, molecular bases and implications in human health and evolution]. Rev Cienc Salud 2012; 10: 59-71
    PubMedGoogle Scholar
  • 11 Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143-153
    CrossrefPubMedGoogle Scholar
  • 12 Costa EBO, Pacheco C. Epigenética: regulação da expressão gênica em nível transcricional e suas implicações [Epigenetics: gene expression regulation at transcriptional level and its implications]. Semina: Ciências Biológicas e da Saúde (Londrina) 2013; 34: 125-136
    CrossrefPubMedGoogle Scholar
  • 13 Schultz MD, He Y, Whitaker JW. , et al. Human body epigenome maps reveal noncanonical DNA methylation variation. Nature 2015; 523: 212-216
    CrossrefPubMedGoogle Scholar
  • 14 Jirtle RL, Skinner MK. Environmental epigenomics and disease susceptibility. Nat Rev Genet 2007; 8: 253-262
    CrossrefPubMedGoogle Scholar
  • 15 Dolinoy DC, Jirtle RL. Environmental epigenomics in human health and disease. Environ Mol Mutagen 2008; 49: 4-8
    CrossrefPubMedGoogle Scholar
  • 16 Linden R. Terapia gênica: o que é, o que não é e o que será [Gene therapy: what it is, what it is not and what it will be]. Estud Av 2010; 24: 31-69
    PubMedGoogle Scholar
  • 17 Crews D, Gillette R, Scarpino SV, Manikkam M, Savenkova MI, Skinner MK. Epigenetic transgenerational inheritance of altered stress responses. Proc Natl Acad Sci U S A 2012; 109: 9143-9148
    CrossrefPubMedGoogle Scholar
  • 18 Babenko O, Kovalchuk I, Metz GA. Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neurosci Biobehav Rev 2015; 48: 70-91
    CrossrefPubMedGoogle Scholar
  • 19 Bellavite P, Pettigrew A. Miasms and modern pathology. Homeopathy 2004; 93: 65-66
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Gulati R. The concept of miasm. Homeopathy 2010; 99: 150
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Khuda-Bukhsh AR. Potentized homoeopathic drugs act through regulation of gene-expression: a hypothesis to explain their mechanism and pathways of action in vitro. Complement Ther Med 1997; 5: 43-46
    CrossrefPubMedGoogle Scholar
  • 22 Khuda-Bukhsh AR. Towards understanding molecular mechanisms of action of homeopathic drugs: an overview. Mol Cell Biochem 2003; 253: 339-345
    CrossrefPubMedGoogle Scholar
  • 23 Khuda-Bukhsh AR. Current trends in high dilution research with particular reference to gene regulatory hypothesis. Nucleus 2014; 57: 3-17
    CrossrefPubMedGoogle Scholar
  • 24 Kay PH, Khuda-Bukhsh AR. The contribution of homeogenomic and homeogenetic studies in the support of the practice of homoeopathy. Indian J Res Homoeopathy 2016; 10: 101-107
    CrossrefPubMedGoogle Scholar
  • 25 Dei A, Bernardini S. Hormetic effects of extremely diluted solutions on gene expression. Homeopathy 2015; 104: 116-122
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Bellavite P, Signorini A, Marzotto M, Moratti E, Bonafini C, Olioso D. Cell sensitivity, non-linearity and inverse effects. Homeopathy 2015; 104: 139-160
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Agência Nacional de Vigilância Sanitária (ANVISA) [The National Health Surveillance Agency]. Farmacopeia Homeopática Brasileira [Brazilian Homeopathic Pharmacopoeia]. 3rd ed. Brasília: ANVISA, 2011. Available at: http://portal.anvisa.gov.br/farmacopeia-homeopatica . Accessed September 20, 2018
    PubMedGoogle Scholar
  • 28 Agência Nacional de Vigilância Sanitária (ANVISA) [The National Health Surveillance Agency]. Resolução da Diretoria Colegiada – RDC n° 67, de 08 de outubro de 2007. Diário Oficial da República Federativa do Brasil, Poder Executivo, Brasília, DF, 09 out. 2007. Available at: http://189.28.128.100/dab/docs/legislacao/resolucao67_08_10_07.pdf . Accessed September 20, 2018
    PubMedGoogle Scholar
  • 29 Tan SC, Yiap BC. DNA, RNA, and protein extraction: the past and the present. J Biomed Biotechnol 2009; 2009: 574398
    PubMedGoogle Scholar
  • 30 El-Ashram S, Al Nasr I, Suo X. Nucleic acid protocols: extraction and optimization. Biotechnol Rep (Amst) 2016; 12: 33-39
    PubMedGoogle Scholar
  • 31 Qiagen. QIAsymphony® DSP DNA Instructions for Use (Handbook), 2015. Available at: https://www.qiagen.com/us/resources/download.aspx?id=8bc88dad-4140-467e-a1f0-e390fd193865&lang=en . Accessed September 20, 2018
    PubMedGoogle Scholar
  • 32 Conselho Nacional de Saúde (Brasil). Resolução CNS N° 340, de 8 de julho de 2004. Diretrizes para Análise Ética e Tramitação dos Projetos de Pesquisa da Área Temática Especial de Genética Humana. Available at: http://bvsms.saude.gov.br/bvs/saudelegis/cns/2004/res0340_08_07_2004.html . Accessed September 20, 2018
    PubMedGoogle Scholar
  • 33 Gene Therapy Net. Gene Therapy Clinical Trials Regulatory Affairs. Available at: http://www.genetherapynet.com/regulatory-affairs.html . Accessed September 20, 2018
    PubMedGoogle Scholar
  • 34 Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? A systematic review. Br Homeopath J 2000; 89: S35-S38
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Dantas F. Do homeopathic medicines cause drug-dependent adverse effects or aggravations?. Rev Homeopatia (São Paulo) 2017; 80: 142-150
    PubMedGoogle Scholar
  • 36 Khuda-Buksh AR, Saha SK, Roy S. Evidence in support of gene regulatory hypothesis: gene expression profiling manifests homeopathy effects more than placebo. Int J High Dilution Res 2013; 12: 162-167
    PubMedGoogle Scholar
  • 37 Bigagli E, Luceri C, Bernardini S, Dei A, Filippini A, Dolara P. Exploring the effects of homeopathic Apis mellifica preparations on human gene expression profiles. Homeopathy 2014; 103: 127-132
    Article in Thieme ConnectPubMedGoogle Scholar
  • 38 Marzotto M, Olioso D, Brizzi M, Tononi P, Cristofoletti M, Bellavite P. Extreme sensitivity of gene expression in human SH-SY5Y neurocytes to ultra-low doses of Gelsemium sempervirens. BMC Complement Altern Med 2014; 14: 104
    CrossrefPubMedGoogle Scholar
  • 39 Olioso D, Marzotto M, Moratti E, Brizzi M, Bellavite P. Effects of Gelsemium sempervirens L. on pathway-focused gene expression profiling in neuronal cells. J Ethnopharmacol 2014; 153: 535-539
    CrossrefPubMedGoogle Scholar
  • 40 Marzotto M, Olioso D, Bellavite P. Gene expression and highly diluted molecules. Front Pharmacol 2014; 5: 237
    PubMedGoogle Scholar
  • 41 Bellavite P, Bonafini C, Marzotto M. Experimental neuropharmacology of Gelsemium sempervirens: recent advances and debated issues. J Ayurveda Integr Med 2018; 9: 69-74
    CrossrefPubMedGoogle Scholar
  • 42 Sunila ES, Kuttan R, Preethi KC, Kuttan G. Dynamized preparations in cell culture. Evid Based Complement Alternat Med 2009; 6: 257-263
    CrossrefPubMedGoogle Scholar
  • 43 Preethi K, Ellanghiyil S, Kuttan G, Kuttan R. Induction of apoptosis of tumor cells by some potentiated homeopathic drugs: implications on mechanism of action. Integr Cancer Ther 2012; 11: 172-182
    CrossrefPubMedGoogle Scholar
  • 44 Frenkel M, Mishra BM, Sen S. , et al. Cytotoxic effects of ultra-diluted remedies on breast cancer cells. Int J Oncol 2010; 36: 395-403
    PubMedGoogle Scholar
  • 45 Samadder A, Das S, Das J, Paul A, Boujedaini N, Khuda-Bukhsh AR. The potentized homeopathic drug, Lycopodium clavatum (5C and 15C) has anti-cancer effect on HeLa cells in vitro. J Acupunct Meridian Stud 2013; 6: 180-187
    CrossrefPubMedGoogle Scholar
  • 46 Arora S, Aggarwal A, Singla P, Jyoti S, Tandon S. Anti-proliferative effects of homeopathic medicines on human kidney, colon and breast cancer cells. Homeopathy 2013; 102: 274-282
    Article in Thieme ConnectPubMedGoogle Scholar
  • 47 Bishayee K, Sikdar S, Khuda-Bukhsh AR. Evidence of an epigenetic modification in cell-cycle arrest caused by the use of ultra-highly-diluted Gonolobus condurango extract. J Pharmacopuncture 2013; 16: 7-13
    CrossrefPubMedGoogle Scholar
  • 48 Sikdar S, Kumar Saha S, Rahman Khuda-Bukhsh A. Relative apoptosis-inducing potential of homeopathic Condurango 6c and 30c in h460 lung cancer cells in vitro: apoptosis-induction by homeopathic Condurango in h460 cells. J Pharmacopuncture 2014; 17: 59-69
    CrossrefPubMedGoogle Scholar
  • 49 Arora S, Tandon S. DNA fragmentation and cell cycle arrest: a hallmark of apoptosis induced by Ruta graveolens in human colon cancer cells. Homeopathy 2015; 104: 36-47
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Saha S, Bhattacharjee P, Guha D. , et al. Sulphur alters NFκB-p300 cross-talk in favour of p53-p300 to induce apoptosis in non-small cell lung carcinoma. Int J Oncol 2015; 47: 573-582
    CrossrefPubMedGoogle Scholar
  • 51 Mondal J, Samadder A, Khuda-Bukhsh AR. Psorinum 6 × triggers apoptosis signals in human lung cancer cells. J Integr Med 2016; 14: 143-153
    CrossrefPubMedGoogle Scholar
  • 52 Khuda-Bukhsh AR, Bhattacharyya SS, Paul S, Dutta S, Boujedaini N, Belon P. Modulation of signal proteins: a plausible mechanism to explain how a potentized drug Secale cor 30c diluted beyond Avogadro's limit combats skin papilloma in mice. Evid Based Complement Alternat Med 2011; 2011: 286320
    PubMedGoogle Scholar
  • 53 Das D, De A, Dutta S, Biswas R, Boujedaini N, Khuda-Bukhsh AR. Potentized homeopathic drug Arsenicum Album 30C positively modulates protein biomarkers and gene expressions in Saccharomyces cerevisiae exposed to arsenate. J Chin Integr Med 2011; 9: 752-760
    CrossrefPubMedGoogle Scholar
  • 54 De A, Das D, Dutta S, Chakraborty D, Boujedaini N, Khuda-Bukhsh AR. Potentiated homeopathic drug Arsenicum Album 30C inhibits intracellular reactive oxygen species generation and up-regulates expression of arsenic resistance gene in arsenite-exposed bacteria Escherichia coli. J Chin Integr Med 2012; 10: 210-227
    CrossrefPubMedGoogle Scholar
  • 55 Das S, Saha SK, De A, Das D, Khuda-Bukhsh AR. Potential of the homeopathic remedy, Arnica Montana 30C, to reduce DNA damage in Escherichia coli exposed to ultraviolet irradiation through up-regulation of nucleotide excision repair genes. J Chin Integr Med 2012; 10: 337-346
    CrossrefPubMedGoogle Scholar
  • 56 Marotti I, Betti L, Bregola V. , et al. Transcriptome profiling of wheat seedling following treatment with ultrahigh diluted arsenic trioxide. Evid Based Complement Alternat Med 2014; 2014: 851263
    PubMedGoogle Scholar
  • 57 Khuda-Bukhsh AR, Sikdar S. Condurango 30c induces epigenetic modification of lung cancer-specific tumour suppressor genes via demethylation. Forsch Komplement Med 2015; 22: 172-179
    PubMedGoogle Scholar
  • 58 Saha SK, Roy S, Khuda-Bukhsh AR. Ultra-highly diluted plant extracts of Hydrastis canadensis and Marsdenia condurango induce epigenetic modifications and alter gene expression profiles in HeLa cells in vitro. J Integr Med 2015; 13: 400-411
    CrossrefPubMedGoogle Scholar
  • 59 Olioso D, Marzotto M, Bonafini C, Brizzi M, Bellavite P. Arnica Montana effects on gene expression in a human macrophage cell line. Evaluation by quantitative real-time PCR. Homeopathy 2016; 105: 131-147
    Article in Thieme ConnectPubMedGoogle Scholar
  • 60 Olioso D, Marzotto M, Bonafini C, Brizzi M, Bellavite P. Response to commentary: Arnica montana effects on gene expression in a human macrophage cell line. Evaluation by quantitative real-time PCR. Front Immunol 2016; 7: 320
    PubMedGoogle Scholar
  • 61 Olsen S. Effects of ultra-high dilutions of sodium butyrate on viability and gene expression in HEK 293 cells. Homeopathy 2017; 106: 32-36
    Article in Thieme ConnectPubMedGoogle Scholar